Dr. Martens plc (LON:DOCS) Insider Kenny Wilson Acquires 199 Shares

Dr. Martens plc (LON:DOCSGet Free Report) insider Kenny Wilson purchased 199 shares of Dr. Martens stock in a transaction dated Wednesday, December 11th. The stock was bought at an average price of GBX 76 ($0.96) per share, with a total value of £151.24 ($190.89).

Kenny Wilson also recently made the following trade(s):

  • On Thursday, September 26th, Kenny Wilson acquired 30,000 shares of Dr. Martens stock. The stock was bought at an average price of GBX 55 ($0.69) per share, with a total value of £16,500 ($20,825.44).

Dr. Martens Stock Down 0.6 %

Dr. Martens stock opened at GBX 76.55 ($0.97) on Friday. Dr. Martens plc has a fifty-two week low of GBX 49.32 ($0.62) and a fifty-two week high of GBX 100 ($1.26). The firm has a market capitalization of £736.20 million, a PE ratio of 1,093.57, a P/E/G ratio of 6.40 and a beta of 0.11. The company’s 50-day moving average is GBX 59.81 and its 200-day moving average is GBX 67.37. The company has a debt-to-equity ratio of 129.55, a current ratio of 2.85 and a quick ratio of 1.13.

Dr. Martens Cuts Dividend

The company also recently disclosed a dividend, which will be paid on Tuesday, April 8th. Shareholders of record on Thursday, March 6th will be issued a GBX 0.85 ($0.01) dividend. This represents a yield of 1.47%. The ex-dividend date is Thursday, March 6th. Dr. Martens’s dividend payout ratio is 4,285.71%.

Dr. Martens Company Profile

(Get Free Report)

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

See Also

Insider Buying and Selling by Quarter for Dr. Martens (LON:DOCS)

Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.